The Healthcare Industry at the BIG 2024 Trade Show
On October 10, 2024, Bpifrance’s BIG exhibition brought together key players in healthcare innovation, providing an exceptional showcase for the latest advancements in the field.
Companies such as Arkhn, Whitelab Genomics, Hope Valley AI, Nova Insilico, and Cherry Biotech presented fascinating projects there, demonstrating the rapid advancements in technology and science in the healthcare sector.
Three topics in particular caught Dynergie's attention:
- Managing Health Data in the Face of Exponential Growth
- The Revolutionary Impact of Artificial Intelligence on Biomedical Research
- Organoids and organs-on-a-chip: promising tools for the future of medical research

The Importance of Health Data for Personalized Care
The healthcare sector derives significant benefits from health data, particularly through personalized care. Each patient generates an increasing volume of information that is essential for refining diagnoses and accelerating treatment. The secure and structured exchange of this data between hospitals and physicians is essential for optimizing the patient care pathway.
The complex and highly confidential nature of health data makes it difficult to process. This is where Arkhn comes in—a company that offers software designed to read and structure this data, thereby automating repetitive tasks in hospitals. Using artificial intelligence, Arkhn simplifies the interpretation of this data, enabling healthcare professionals to make informed decisions in real time.
AI: Much More Than Just a Trend
The use of AI in healthcare is a true revolution, paving the way for faster and more targeted care. Digital twins, for example, can simulate tumors and organs to improve medical decision-making. Startups like Hope Valley AI are developing tools capable of detecting early signs of cancer, outperforming traditional screening methods.
Several companies stand out for their innovations in AI applied to healthcare:
- Nova In Silico uses AI to create control groups based on real-world data, thereby facilitating clinical trials.
- White Lab Genomics focuses on developing innovative gene therapies and aims to drastically reduce the time it takes to create new drugs.
Artificial intelligence is revolutionizing the healthcare sector by optimizing care, diagnostics, and research processes. However, this revolution must be accompanied by robust safeguards for the security and privacy of health data.
Organoids and organs-on-a-chip
Organoids and organs-on-a-chip represent cutting-edge technologies in medical research.
- Organoids are miniature three-dimensional models of organs, enabling a more detailed study of their functions.
- Organ-on-a-chip systems are two-dimensional structures engineered to replicate specific conditions under study.
These approaches offer ethical alternatives to animal testing and improve the accuracy of drug testing, while reducing development costs and timelines. Cherry Biotech stands out for its organ-on-a-chip models, which help identify treatments for specific diseases more effectively.
These technological advances herald the dawn of new scientific discoveries, promising faster, more effective medical care that adheres to ethical standards.
In summary
Every day, the healthcare sector sees the emergence of projects that are revolutionizing research and patients’ daily lives. Innovative medical devices, gene therapies, mental health care, surgical robotics… These are just some of the innovations that today’s R&D is developing to improve our health in the future.
These projects are primarily led by startups, some of which have emerged from research labs or large corporations, while others have been inspired by challenges that healthcare professionals encounter in their daily work. Regardless of their origins, these companies and projects come to life thanks to ambitious entrepreneurs committed to the future.
If you’d like to learn more about how to accelerate your MedTech and BioTech projects to maximize their chances of success, Dynergie supports you every step of the way—from the initial stages through to market launch.
